Cardiac Safety Services Market by Type (Standalone, Integrated), Services (ECG/Holter measurement, Blood Pressure measurement, Cardiac Imaging, Thorough QT Studies), End User (Pharmaceutical, Biopharma, CROs), Region - Global Forecast to 2027.” The cardiac safety services market is projected to reach USD 1.0 billion by 2027 from USD 0.6 billion in 2022, at a CAGR of 11.2% during the forecast period. The growing R&D expenditure in the pharmaceutical & biopharmaceutical industry is likely to drive the market growth. Furthermore, factors like, outsourcing of R&D activities by the pharma companies along with a surge in the number of clinical trials is also likely to boost market growth.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174488627
Browse in-depth TOC on "Cardiac Safety Services Market”
113 – Tables
28 – Figures
132 – Pages
Key Market Players
The prominent players operating in this market include Laboratory Corporation of America Holdings (US), Koninklijke Philips N.V. (Netherlands), Clario (US), Banook Group (France), IQVIA (US), Biotrial (France), Certara (US), Celerion (US), Medpace (US), Ncardia (Netherlands), Richmond Pharmacology (UK), PhysioStim (France), Shanghai Medicilon (China), Pharmaceutical Product Development (US), and SGS (Switzerland). Expansion and acquisitions are the key growth strategies undertaken by these companies to maintain their positions in the market.
Laboratory Corporation of America Holdings (US)
Laboratory Corporation of America Holdings is a healthcare diagnostics company providing comprehensive clinical laboratory services and end-to-end drug development support to various clients, including hospitals, managed care organizations, and biotechnology & pharmaceutical companies. The company operates through two key segments: LabCorp Diagnostics (Dx) and LabCorp Drug Development (DD).
Request Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=174488627
The company provides cardiac safety services through its LabCorp Drug Development segment. This segment provides end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. Its customers comprise pharmaceutical, biotechnology, medical device, and diagnostic companies.
Koninklijke Philips N.V. (Netherlands)
The company offers cardiac safety services through its connected care business segment. In 2021, Philips acquired BioTelemetry, Inc., a medical technology company providing remote cardiac monitoring services, remote blood glucose monitoring services, centralized core lab services for clinical trials, and original equipment manufacturing for healthcare and clinical research customers.
In November 2021, ERT merged with Bioclinica, and the combined company was renamed Clario. Clario is a technology company that generates clinical evidence by fusing scientific knowledge and global scale into the endpoint technology platform. The company focuses on therapeutic areas such as cardiovascular & metabolic, dermatology, gastroenterology, hepatology, infectious diseases, musculoskeletal, neuroscience, oncology, and respiratory diseases. Since 1990, Clario has completed more than 19,000 clinical trials and contributed to 870 regulatory approvals. Between 2019 and 2020, Clario supported 70% of all Federal and Drug Administration (FDA) approvals.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=174488627
Browse Adjacent Market: 3D Bioprinting Market Research Reports & Consulting
Skin Health Foods Market / Dermatology Functional Foods Market by Indication (Skin Conditions, Anti-Aging, Anti-Allergy), Region (North America, Europe, Asia Pacific, Rest of the World), Regulatory Landscape, Pricing Analysis, COVID-19 Impact - Global Forecast to 2026
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their pain points around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 Micro Quadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com/